Medical Science Liaison
Experimental Medicine is the study of the pathogenesis and treatment of disease. Modern experimental medicine represents a rapidly growing body of knowledge involving the determination of diseases processes and the development of appropriate therapies.
The Experimental Medicine Program is intended for individuals seeking a career in research. The Department of Medicine offers opportunities and facilities for advanced studies in Experimental medicine, leading toward the M.Sc. and Ph.D. degrees. Members of the Department direct research programs in a wide range of basic and clinically relevant areas. There are a variety of special interest areas of national and international stature. Specialties within the Experimental Medicine Program include: Cardiology, Endocrinology, Gastroenterology, Hematology, Infectious Diseases, Medical Immunology, Medical Oncology, Molecular Biology, Nephrology, Neurology and Respiratory Medicine.
The principal emphasis of this graduate program is training in research. Success at this level is traditionally measured by the preparation and defense of a thesis. Course work is required of all students, based on the background of the candidate and the degree program. The work of each Ph.D. candidate will be supervised by a candidate’s Committee consisting of not fewer than three members. These may include faculty members from a department other than that in which the candidate is writing the thesis.
Applicants are not required to have a supervisor at the time of applying, but the application won't be reviewed until they secure a supervisor and all required paperwork is submitted.
The Faculty of Graduate and Postdoctoral Studies establishes the minimum admission requirements common to all applicants, usually a minimum overall average in the B+ range (76% at UBC). The graduate program that you are applying to may have additional requirements. Please review the specific requirements for applicants with credentials from institutions in:
Each program may set higher academic minimum requirements. Please review the program website carefully to understand the program requirements. Meeting the minimum requirements does not guarantee admission as it is a competitive process.
Applicants from a university outside Canada in which English is not the primary language of instruction must provide results of an English language proficiency examination as part of their application. Tests must have been taken within the last 24 months at the time of submission of your application.
Minimum requirements for the two most common English language proficiency tests to apply to this program are listed below:
Overall score requirement: 96
Overall score requirement: 7.0
Some programs require additional test scores such as the Graduate Record Examination (GRE) or the Graduate Management Test (GMAT). The requirements for this program are:
The GRE is not required.
For admission to the PhD program in Experimental Medicine, the student must hold a M.Sc. degree in life sciences, biology, zoology, biochemistry, or related disciplines.
All applicants have to submit transcripts from all past post-secondary study. Document submission requirements depend on whether your institution of study is within Canada or outside of Canada.
A minimum of three references are required for application to graduate programs at UBC. References should be requested from individuals who are prepared to provide a report on your academic ability and qualifications.
Many programs require a statement of interest, sometimes called a "statement of intent", "description of research interests" or something similar.
Students in research-based programs usually require a faculty member to function as their supervisor. Please follow the instructions provided by each program whether applicants should contact faculty members.
Permanent Residents of Canada must provide a clear photocopy of both sides of the Permanent Resident card.
All applicants must complete an online application form and pay the application fee to be considered for admission to UBC.
|Fees||Canadian Citizen / Permanent Resident / Refugee / Diplomat||International|
|Installments per year||3||3|
|Tuition per installment||$1,732.53||$3,043.77|
|Tuition per year|
(plus annual increase, usually 2%-5%)
|Int. Tuition Award (ITA) per year (if eligible)||$3,200.00 (-)|
|Other Fees and Costs|
|Student Fees (yearly)||$1,052.34 (approx.)|
|Costs of living (yearly)||starting at $17,126.20 (check cost calculator)|
Applicants to UBC have access to a variety of funding options, including merit-based (i.e. based on your academic performance) and need-based (i.e. based on your financial situation) opportunities.
Successful applicants who will start the Ph.D. program and who do not hold a major scholarship, will receive a minimum stipend of $22,000 per year from their supervisor.
All applicants are encouraged to review the awards listing to identify potential opportunities to fund their graduate education. The database lists merit-based scholarships and awards and allows for filtering by various criteria, such as domestic vs. international or degree level.
Graduate programs may have Teaching Assistantships available for registered full-time graduate students. Full teaching assistantships involve 12 hours work per week in preparation, lecturing, or laboratory instruction although many graduate programs offer partial TA appointments at less than 12 hours per week. Teaching assistantship rates are set by collective bargaining between the University and the Teaching Assistants' Union.
Many professors are able to provide Research Assistantships (GRA) from their research grants to support full-time graduate students studying under their direction. The duties usually constitute part of the student's graduate degree requirements. A Graduate Research Assistantship is a form of financial support for a period of graduate study and is, therefore, not covered by a collective agreement. Unlike other forms of fellowship support for graduate students, the amount of a GRA is neither fixed nor subject to a university-wide formula. The stipend amounts vary widely, and are dependent on the field of study and the type of research grant from which the assistantship is being funded. Some research projects also require targeted research assistance and thus hire graduate students on an hourly basis.
Canadian and US applicants may qualify for governmental loans to finance their studies. Please review eligibility and types of loans.
All students may be able to access private sector or bank loans.
Many foreign governments provide support to their citizens in pursuing education abroad. International applicants should check the various governmental resources in their home country, such as the Department of Education, for available scholarships.
The possibility to pursue work to supplement income may depend on the demands the program has on students. It should be carefully weighed if work leads to prolonged program durations or whether work placements can be meaningfully embedded into a program.
Canadian residents with RRSP accounts may be able to use the Lifelong Learning Plan (LLP) which allows students to withdraw amounts from their registered retirement savings plan (RRSPs) to finance full-time training or education for themselves or their partner.
Please review Filing taxes in Canada on the student services website for more information.
Applicants have access to the cost calculator to develop a financial plan that takes into account various income sources and expenses.
124 students graduated between 2005 and 2013: 1 graduate is seeking employment; for 16 we have no data (based on research conducted between Feb-May 2016). For the remaining 107 graduates:
These statistics show data for the Doctor of Philosophy in Experimental Medicine (PhD). Data are separated for each degree program combination. You may view data for other degree options in the respective program profile.
|2011||Dr. Crome examined the development, function and regulation of a novel immune cell population that directs immune responses in health and disease. She provided new research tools and identified novel targets for therapies aimed at preventing harmful immune responses such as transplant rejection and autoimmunity.|
|2011||Dr. Moussavi examined the efficacy of a previously unused oncolytic virus in mouse models of prostate cancer. She found that one strain of this virus was able to selectively infect and destroy tumour cells while sparing normal tissue. This research provides support for the use of the virus as a treatment for prostate cancer.|
|2011||Dr. Shadgan developed a noninvasive optical method for monitoring changes in muscle oxygenation and blood flow. This new method will improve speed and accuracy of diagnosis of ischemic conditions in the limb muscles of high-risk patients, leading to improved care for patients and substantial cost savings.|
|2011||Dr Kulic identified RBPJ as a protein that is able to suppress tumor growth. This research shows that RBPJ is inappropriately absent in breast cancer and other cancer types and that loss of this protein aids cancer growth by increasing survival of tumor cells.|
|2011||Dr. Rahmani has successfully designed and completed a research project delineating a clinically relevant delivery system for Stratifin in the management of post-burn and post-surgical hypertrophic scarring. The potential clinical applicability of her research is extensive given the personal, social, and financial consequences of burn injuries.|
|2011||Dr. Li showed that the tumor suppressor ING4 inhibits melanoma occurrence and growth. ING4 may serve as a predictor for melanoma patient outcome, as well as a novel therapeutic target in melanoma treatment.|
|2011||Dr. Bergstrom showed that goblet cells, the main mucus-producing cells in the intestinal tract, play a critical role protecting the intestine against pathogenic bacteria. These results highlight a new role for goblet cells in host defense in the gut, and point to them as novel targets for therapy during bacterially-induced intestinal diseases.|
|2010||Dr. Chang studied the role of a protein called Notch in the development and maintenance of blood vessels. She found that Notch activation ensures vessel integrity through its involvement in the formation of the muscular wall of embryonic arteries from precursor cells and the increased survival of adult cells lining the blood vessel.|
|2010||Dr. Anthony analyzed the global changes in protein concentrations in human cancer cells as these cells were undergoing programmed cell death, discovering previously unidentified alterations in the levels of some proteins. Since the aim of all cancer treatment is to induce cancer cells to die preferentially, this work has the potential to lead to new therapeutic approaches to cancer treatment.|
|2010||Dr. Avina studied the risk of cardiovascular disease in patients with rheumatoid arthritis. He found that arthritis patients had greater risk of dying from CVD than the general population, and that use of glucocorticoids was associated with increased risk of myocardial infarction but not with stroke.|
Experimental Medicine offers research opportunities in the following specialties: cardiology, cancer biology, dermatology, gastroenterology, hematology/oncology, infectious diseases, molecular medicine, nephrology, neurology, and respiratory medicine. All these fields can involve patients and/or experimental animal models.